FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091713 [Registered on: 25/07/2025] Trial Registered Prospectively
Last Modified On: 24/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Single Arm Study 
Public Title of Study   Nutool with Roghan-e-khashkhash in insomnia  
Scientific Title of Study   Efficacy of nutool-e-raas with roghan-e-khashkhash in insomnia (sahar)-an open labelled interventional clinical trial 
Trial Acronym  DSM-IV 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ishaq Ahmad 
Designation  PG scholar 
Affiliation  State Unani Medical College and hospital himmatganj Prayagraj, UP 
Address  ground floor, Department of Ilaj-Bit-Tadbeer (IBT), State Unani Medical College and hospital Himmatganj Allahabad UTTAR PRADESH 211016 India

Allahabad
UTTAR PRADESH
211016
India 
Phone  6307235831  
Fax    
Email  ishaqahmad4800@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Jamal Akhtar 
Designation  Professor 
Affiliation  State takmeel ut tib college, lucknow 
Address  6th floor, Indira Bhawan, Lucknow-226001

Lucknow
UTTAR PRADESH
226001
India 
Phone  8052142175  
Fax    
Email  drjamalakhtar@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Ishaq Ahmad 
Designation  PG scholar 
Affiliation  State Unani Medical College and hospital himmatganj Prayagraj, UP 
Address  room no.2, ground floor, department of ilaj-bit-tadbeer, state unani medical college and hospital, himmatganj, prayagraj-UP

Lucknow
UTTAR PRADESH
226001
India 
Phone  8052142175  
Fax    
Email  ishaqahmad4800@gmail.com  
 
Source of Monetary or Material Support  
state unani medical college prayagraj, ministry of AYUSH, U.P. govt,India, PIN No. 211016 
 
Primary Sponsor  
Name  State unani medical college and hospital 
Address  Department of Ilaj-Bit-Tadbeer (IBT), State unani medical college and hospital, Himmatganj,Prayagraj, Uttar pradesh (211016) 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ishaq Ahmad  State Unani Medical College and HAHRDM Hospital  department of IBT, State Unani Medical College and HAHRDM Hospital-211016
Allahabad
UTTAR PRADESH 
6307235831

ishaqahmad4800@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G470||Insomnia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  Nutool therapy (irrigation)  participants will be treated with nutool with roghan e khashkhash for 23 days. There will be total 8 sittings. Each sitting will be of 20-30 minutes on 1, 3rd, 5th, 7th, 11th, 15th, 19th, and 23rd day. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patient with age 20 years to 60 years of all gender.
2. Clinically diagnosed Patient having a insomnia severity index (ISI) score (more than 8
- less than 21).
3. Patient who will give consent and able to do follow up.
 
 
ExclusionCriteria 
Details  1. Pregnant and lactating women.
2. Patient having any systemic and metabolic diseases.
3. Unstable mentally retarded and bed ridden patient.
4. Patient with history of trauma and accident involving skull.
5. Concomitant skin disease involving the skull like tinea capitis,scalp
psoriasis,etc.
6.Patients on sedative and hypnotic drugs, hormonal therapy or any other
psychosomatic drug.
7. Patients who do not report for follow up and who refuses to join the
study. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Insomnia
 
7th, 14th, 23rd Day 
 
Secondary Outcome  
Outcome  TimePoints 
QOL (SF-36)
HAQ - health assessment questionnaire 
0 to 23th days 
 
Target Sample Size   Total Sample Size="46"
Sample Size from India="46" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   18/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Insomnia is a Latin word derived from insomnia which is composed of ‘in’ means not and ‘somnus’ means sleep which means no sleep . Insomnia is an acute or chronic inability to initiate or maintain sleep adequately at night at least 3 night a week for at least 3 months . An estimated (6%-10%) of the adult population suffer from insomnia. which is more common in women. The prevalence of insomnia is increased with advancing age. It may be due to continuous fluctuation in hormones. it is estimated that 40% of all insomnia patient have a co-existing psychiatric disorder. depression is most common disease due to due to its chronicity and insomnia is associated with substantial impairment in an individual quality of life. In allopathic system of medicine treatment Options for insomnia are pharmacologic treatment as sedative like Triazolam (Halcion) or Zolpidem (Ambien) or rapidly acting drugs are more effective, such as flurazepam, clonazepam, Quazepam (Doral) for patient with persisting insomnia, but these are not curative for insomnia rather these drug may cause side effect like, debilities, loss of libido, laziness, addiction etc, which is again call for an alternative management.
Unani physician have been successfully treating insomnia (sahar) through Nutool (irrigation therapy) since ancient times, but scientific documentation is not available. So in the light of aforementioned facts, i am determined to conduct a clinical trial to appraise the efficacy of Nutool (irrigation therapy) in management of Sahar (insomnia). Nutool is a regimenal therapy (Ilaj-bit-tadbeer). and it is a novel method, in which decoction of certain drugs or medicated oils are poured over specific sites at certain height in some specific disease. In unani system of medicine, the treatment of Sahar (insomnia) is the restoration of brain homeostasis through various unani tadbeer (therapies), along with dietary components, mubarrid and murattib advia, among them NUTOOL therapy is one of the most commonly used tadbeer for the management of Sahar . The present study has been designed to evaluate the efficacy of nutool-e-raas (irrigation of head) with Roghan-e-Khaskhash in the management of insomnia
 
Close